On the Brink of Extinction: the Future of Translational Physician-scientists in the United States
Overview
General Medicine
Affiliations
Over the past decade, we have seen an unparalleled growth in our knowledge of cancer biology and the translation of this biology into a new generation of therapeutic tools that are changing cancer treatment outcomes. With the continued explosion of new biologic discoveries, we find ourselves with a limited number of trained and engaged translational physician-scientists capable of bridging the chasm between basic science and clinical science. Here, we discuss the current state translational physician-scientists find themselves in and offer solutions to navigate during this difficult time.
Structured programs to train the next generation of clinician scientists.
Melk A, Grabitz C, Ernst J, Saenger T, Degraeuwe E, Beck Schimmer B Nat Med. 2025; 31(1):24-27.
PMID: 39747682 DOI: 10.1038/s41591-024-03339-2.
Esan O, Ogunoye B, Sodimu T, Olayode O, Okoro N, Adeyanju T Niger Med J. 2024; 65(5):691-704.
PMID: 39633699 PMC: 11612325. DOI: 10.60787/nmj-v65i3.536.
Mokhtari B, Badalzadeh R, Ghaffarifar S BMC Med Educ. 2024; 24(1):1313.
PMID: 39543546 PMC: 11566606. DOI: 10.1186/s12909-024-06166-8.
Liao S, Lavender C, Zhai H, Zhou X BMC Med Educ. 2023; 23(1):94.
PMID: 36747173 PMC: 9900976. DOI: 10.1186/s12909-023-04069-8.
Dovat S, Gowda C, Mailman R, Parent L, Huang X Adv Med Educ Pract. 2022; 13:1039-1050.
PMID: 36120395 PMC: 9480202. DOI: 10.2147/AMEP.S365953.